Texas House Bill HB4572

Texas 2009 - 81st Regular

Caption

Relating to insurance coverage for certain devices that facilitate insulin therapy and enhance glucose control in the treatment of diabetes.

Impact

The proposed changes in HB 4572 will amend Sections 1358.051(1) and (2) of the Texas Insurance Code. This legislative move is particularly impactful as it will ensure that insurance policies delivered or renewed after January 1, 2010, will include coverage for a more comprehensive range of diabetes management devices. The inclusion of noninvasive glucose monitors and diabetic supplies under insurance plans is expected to reduce the financial burden on patients, making it more feasible for them to manage their diabetes effectively.

Summary

House Bill 4572 provides a significant update to the insurance regulations in the state concerning diabetes management. The bill focuses on expanding insurance coverage for various devices that facilitate insulin therapy and enhance glucose control in the treatment of diabetes. This includes coverage for blood glucose monitors, insulin pumps, and other crucial diabetes-related supplies. If passed, the bill will ensure that individuals with diabetes have easier access to the necessary tools for monitoring and managing their condition effectively.

Contention

While HB 4572 has potential benefits, including increased access to essential healthcare devices for diabetics, there may be some concerns regarding the implications for insurance providers. Discussions may evoke questions around the cost to insurers and the potential for increased premiums as a result of expanded coverage. Additionally, there could be debates on the necessity and efficacy of certain devices, which might affect the decision-making process of insurance coverage criteria. However, the bill emphasizes the importance of promoting better health outcomes for diabetes patients overall.